Cisco Systems agrees to buy ArrowPoint for $5.7 billion

Article Abstract:

Cisco Systems is paying $5.7 billion in stock to purchase network switching equipment maker ArrowPoint Communications. The deal gives market leader Cisco a key technology in the emerging fields of content switching and load balancing in distributing Internet content. The shares of both companies rose significantly when the merger was announced on Wall Street.

Mergers, acquisitions and divestments, Internet, ArrowPoint Communications Inc., ARPT

---

Cisco's $662 million profit tops forecasts

Article Abstract:

Cisco Systems Inc. reported a third-quarter earnings profit that beat analyst's estimates at $662 million. The supplier of Internet hardware reported charges from acquisitions and mergers.

Sales, profits & dividends, Company sales and earnings, Company earnings/profit

---

Cisco results come in short of forecast; company foresees drop in revenue next quarter

Article Abstract:

Reporting lower than expected second quarter revenue of $6.75 billion, Cisco Systems confirmed fears that the tech slowdown is affecting the earnings of large equipment makers. The company, which had previously posted 44 consecutive quarters of revenue growth, also shocked analysts by predicting a 5% decline in revenue for the next quarter. Although CEO John Chambers claimed these numbers reflect a temporary downturn, analysts worry that Cisco's financial problems may extend forward into the summer.

Similar abstracts:

• Abstracts: Time Warner scales back its forecast; shares take a beating, as do those of AOL. IDT says Liberty Media will buy stake
• Abstracts: The case for a breakup; best competition for the Windows system exists within Microsoft, government says. Antitrust deal is called big victory for Microsoft
• Abstracts: Merger wins votes at AOL and Warner; companies now await regulatory approvals. Digital future up for grabs in cable battle
• Abstracts: A study says many traditional marketers are quickly becoming devotees of cyberspace. Many big brand names steer clear of the 'Dr. Laura' show

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.